PCI围手术期强化他汀治疗:从证据到实践

被引：3

作者：

霍勇

机构：

[1] 北京大学第一医院

来源：

心血管病学进展 | 2009年 / 30卷 / 04期

关键词：

强化他汀治疗; 患者; 术前; PCI; 围手术期; 他汀药物;

D O I：

暂无

中图分类号：

R541.4 [冠状动脉（粥样）硬化性心脏病（冠心病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：546 / 549

页数：4

共 12 条

[1] Comparison of Effectiveness of Atorvastatin 10 mg Versus 80 mg in Reducing Major Cardiovascular Events and Repeat Revascularization in Patients With Previous Percutaneous Coronary Intervention (Post Hoc Analysis of the Treating to New Targets [TNT] Study) [J].

Johnson, Colleen ;

Waters, David D. ;

DeMicco, David A. ;

Breazna, Andrei ;

Bittner, Vera ;

Greten, Heiner ;

Grundy, Scott M. ;

LaRosa, John C. .

AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (10) :1312-1317

[2] Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention [J].

Patti, Giuseppe ;

Nusca, Annunziata ;

Chello, Massimo ;

Pasceri, Vincenzo ;

D'Ambrosio, Andrea ;

Vetrovec, George W. ;

Di Sciascio, Germano .

AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (03) :279-285

[3]

Atorvastatin Pretreatment Improves Outcomes in Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention[J] . Giuseppe Patti,Vincenzo Pasceri,Giuseppe Colonna,Marco Miglionico,Dionigi Fischetti,Gennaro Sardella,Antonio Montinaro,Germano Di Sciascio.Journal of the American College of Cardiology . 2007 (12)

[4]

Coronary Stenting and Inflammation: Implications for Further Surgical and Medical Treatment[J] . Walter J. Gomes,Enio Buffolo.The Annals of Thoracic Surgery . 2006 (5)

[5]

Protection From Procedural Myocardial Injury by Atorvastatin Is Associated With Lower Levels of Adhesion Molecules After Percutaneous Coronary Intervention[J] . Giuseppe Patti,Massimo Chello,Vincenzo Pasceri,Diego Colonna,Annunziata Nusca,Marco Miglionico,Andrea D’Ambrosio,Elvio Covino,Germano Di Sciascio.Journal of the American College of Cardiology . 2006 (8)

[6] Acute effect of atorvastatin on coronary circulation measured by transthoracic Doppler echocardiography in patients without coronary artery disease by angiography [J].

Hinoi, T ;

Matsuo, S ;

Tadehara, F ;

Tsujiyama, S ;

Yamakido, M .

AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (01) :89-91

[7] Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients [J].

Sanguigni, V ;

Pignatelli, P ;

Lenti, L ;

Ferro, D ;

Bellia, A ;

Carnevale, R ;

Tesauro, M ;

Sorge, R ;

Lauro, R ;

Violi, F .

CIRCULATION, 2005, 111 (04) :412-419

[8]

Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention: Results From the ARMYDA （Atorvastatin for Reduction of MYocardial Damage during Angioplasty） Study[J] . Vincenzo Pasceri,Giuseppe Patti,Annunziata Nusca,Christian Pristipino,Giuseppe Richichi,Germano Di Sciascio.Circulation . 2004 (6)

[9] Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? [J].

Kernis, SJ ;

Harjai, KJ ;

Stone, GW ;

Grines, LL ;

Boura, JA ;

O'Neill, WW ;

Grines, CL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (10) :1773-1779

[10]

Long-term clinical events following creatine kinase–myocardial band isoenzyme elevation after successful coronary stenting[J] . Jorge F Saucedo,Roxana Mehran,George Dangas,Mun K Hong,Alexandra Lansky,Kenneth M Kent,Lowell F Satler,Augusto D Pichard,Gregg W Stone,Martin B Leon.Journal of the American College of Cardiology . 2000 (5)

← 1 2 →